Becker’s Behavioral Health

About 2.8% of U.S. residents ages 12 and older — roughly 8 million people — reported past-year psilocybin use, according to a study published April 21 in The American Journal of Psychiatry. The drug is a hallucinogenic compound found in…

Winston-Salem, N.C.-based Novant Health and Los Angeles-based Amae Health are collaborating to expand outpatient care for severe mental illness in Charlotte, N.C..  The partnership will bring Amae’s outpatient care model for severe mental illness — which integrates psychiatry, therapy, primary…

Monrovia, Calif.-based Autism Learning Partners has closed its New York Medicaid panels for new Medicaid and Child Health Plus patients, effective April 17.  The move follows two reimbursement cuts for applied behavior analysis services: a 12.5% reduction that took effect…

More than two-thirds — 68% — of substance use and mental health treatment facilities reported using only an EHR with no paper charts, while 25% used a mix of digital and paper records, according to an April report from the…

The Advanced Research Projects Agency for Health is launching a behavioral health research initiative that will fund up to $139.4 million to develop new therapies.  The initiative, Evidence-Based Validation and Innovation for Rapid Therapeutics in Behavioral Health, will allocate at…

Dallas-based North Texas Behavioral Health Authority has reported a data breach affecting 285,086 individuals, The HIPAA Journal reported April 21.  The organization identified unauthorized activity in its systems around Oct. 15. An investigation found an unauthorized third party accessed its…

The American Foundation for Suicide Prevention and The Jed Foundation plan to combine into a single organization.  The combined entity, the American Foundation for Suicide Prevention/The Jed Foundation, is expected to be completed by this fall, according to an April…

Mothers prescribed at least one sterol biosynthesis-inhibiting medication — including certain antidepressants, antipsychotics, anxiolytics, beta-blockers and statins — had a 1.47-fold higher risk of having a child diagnosed with autism spectrum disorder, according to a study published April 16 in Molecular Psychiatry.…